Financial Services Blog

Blogs October 15, 2021 A New Era for Private Equity and Venture Capital

Private equity firms have taken steps to integrate both environmental, social and governance (ESG) and diversity, equity and inclusion (DEI) into their initiatives. This post addresses those topics, along with PE firms’ investment outlook and how tec…

Blogs October 14, 2021 EisnerAmper’s 6th Annual Alternative Investment Summit: Fireside Chat with CEO Charly Weinstein and Shark Tank’s Barbara Corcoran and Daymond John

A recap of the fireside chat with our CEO Charly Weinstein, Barbara Corcoran, founder of The Corcoran Group, and Daymond John, founder and CEO of FUBU, both of ABC’s Shark Tank. Barbara and Daymond shared the successes and challenges of their respect…

Blogs October 14, 2021 Trends Watch: Market Swings

A conversation with Andrew Dassori of Wavelength Capital Management about his outlook for alternative investments.

Blogs October 07, 2021 Trends Watch: Crypto Investing

A conversation with Sadie Rainey of Makara and Strix Leviathan regarding the outlook for investing in cryptocurrencies.

Blogs September 30, 2021 M&A Trends Since COVID-19

Content focusing on the discussion of current trends at the Alliance of Mergers and Acquisition Advisors (AM&AA) summer conference, “Connect 2021.”

Blogs September 30, 2021 Alternative Investment Industry Outlook on RTO

This content features highlights of conversations with representatives from the alternative investment industry on their organizations’ plans to return to the office.

Blogs September 30, 2021 Trends Watch: M&A for Investment Managers

A conversation with Darin Tuttle of Tuttle Ventures about a shift in the investment management industry.

Blogs September 23, 2021 Trends Watch: Allocations to Private Equity

A conversation with Jeremy Holland of The Riverside Company about the outlook for allocations to private equity.

Blogs September 16, 2021 Trends Watch: Life Sciences

A conversation with Miguel Fidalgo of Project X Management about his outlook for investing in life sciences.